Impact of Canagliflozin on Renoprotection in T2DM

Slideshow

Will SGLT2 inhibitor canagliflozin prove renoprotective in T2DM patients? CANVAS study authors sought to find out.

Recent Videos
Rahul Aggarwal, MD | Credit: LinkedIn
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Alexandra Louise Møller, MS, PhD | Credit: LinkedIn
A panel of 5 experts on Cushing's syndrome
A panel of 5 experts on Cushing's syndrome
Optimizing Diabetes Therapies with New Classifications
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Related Content
Brendon Neuen, MBBS, PhD | Credit: X.com

Brendon Neuen, MBBS, PhD: Expanding Evidence of Combination Therapy with GLP-1 RAs and SGLT2 Inhibitors

Patrick Campbell
September 1st 2024
Article
Diabetes Dialogue: Stelo OTC Availability and Omnipod 5 for Type 2 Diabetes

Diabetes Dialogue: Stelo OTC Availability and Omnipod 5 for Type 2 Diabetes

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
August 27th 2024
Podcast
US FDA logo in black over a white background. | Credit: US Food and Drug Administration

FDA Clears Omnipod 5 AID System for Type 2 Diabetes

Patrick Campbell
August 26th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: Sotagliflozin for T1D and Other ADCES 2024 Highlights

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
August 21st 2024
Podcast
Semaglutide Linked to Suicidal Ideation, New Study Reveals

Semaglutide Linked to Suicidal Ideation, New Study Reveals

Chelsie Derman
August 23rd 2024
Article
HbA1c Highly Predicts NAFLD Disease Severity

HbA1c Highly Predicts NAFLD Disease Severity

Kevin Kunzmann
August 19th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.